Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis

Histiocytic sarcoma (HS) is a rare hematological malignancy with limited treatment options, and it is also prone to complications such as hemophagocytic lymphohistiocytosis (HLH) in the later stages of the disease, leading to difficulties in treatment and poor prognosis. It highlights the importance...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Deng, Yating, Jiang, Yi, Zheng, Wenli, Tan, Yanlin, Yang, Zhiwu, Wang, Zhihua, Xu, Feng, Cheng, Zhao, Yuan, Lingli, Peng, Hongling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030599/
https://www.ncbi.nlm.nih.gov/pubmed/36969238
http://dx.doi.org/10.3389/fimmu.2023.1127599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030599/
https://www.ncbi.nlm.nih.gov/pubmed/36969238
http://dx.doi.org/10.3389/fimmu.2023.1127599

Ejemplares similares